MICHAELA WEHR: Open Payments
NPI 1588848337 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,152 in 153 payments from 17 companies in 2025. Trend: 2023 $2,072 · 2024 $2,188 · 2025 $2,152
Food & beverage: $2,152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $483 |
| Galderma Laboratories, L.P. | 25 | $320 |
| UCB, Inc. | 18 | $211 |
| Janssen Biotech, Inc. | 15 | $192 |
| Novartis Pharmaceuticals Corporation | 15 | $173 |
| Amgen Inc. | 7 | $157 |
| Regeneron Healthcare Solutions, Inc. | 8 | $157 |
| Organon LLC | 10 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $87 |
| GENZYME CORPORATION | 3 | $70 |
Products named: SKYRIZI, RINVOQ, Bimzelx, TREMFYA, NEMLUVIO, OTEZLA, DUPIXENT, AKLIEF.
Industry payments across IN — which companies pay providers there.
